Metastases are the main cause of cancer deaths, but the mechanisms underlying metastatic progression remain poorly understood. We isolated pure populations of cancer cells from primary tumors and metastases from a genetically engineered mouse model of human small cell lung cancer (SCLC) to investigate the mechanisms that drive the metastatic spread of this lethal cancer. Genome-wide characterization of chromatin accessibility revealed the opening of large numbers of distal regulatory elements across the genome during metastatic progression. These changes correlate with copy number amplification of the Nfib locus, and differentially accessible sites were highly enriched for Nfib transcription factor binding sites. Nfib is necessary and sufficient to increase chromatin accessibility at a large subset of the intergenic regions. Nfib promotes pro-metastatic neuronal gene expression programs and drives the metastatic ability of SCLC cells. The identification of widespread chromatin changes during SCLC progression reveals an unexpected global reprogramming during metastatic progression.
INTRODUCTION
Phenotypic changes that occur during development and disease progression are driven by gene expression changes that are themselves governed by regulatory states encoded within the nucleoprotein structure of chromatin (Voss and Hager 2014) . During development and differentiation, tens of thousands of regulatory elements change from inactive to active states (or vice versa), eliciting a concerted transformation of gene expression programs that control cell phenotypes (Zhu et al., 2013) . Numerous targeted methods of probing this landscape, from chromatin immunoprecipitation approaches to assays measuring DNA methylation, have produced insight into the dimensions of this regulation (Schones and Zhao 2008) . Chromatin accessibility, or the genome-wide accounting of loci accessible for transcription factor binding, has been identified as perhaps the single most relevant genomic characteristic correlated with biological activity at a specific locus (Thurman et al., 2012) .
Recent work has begun to catalog chromatin state changes between normal and cancer cells and to define the chromatin landscape of several cancer cell lines (Simon et al., 2014; Stergachis et al., 2013) . The phenotypic changes associated with metastasis likely require widespread changes in gene expression programs that drive invasion, migration, dissemination, and colonization (Sethi and Kang 2011) . However, the specific regulatory changes driving the transition of primary tumors to cells capable of metastatic spread remain largely unexplored.
Small cell lung cancer (SCLC) is a high-grade neuroendocrine carcinoma that accounts for $15% of all lung cancers and causes over 200,000 deaths worldwide each year (Kalemkerian et al., 2013) . The ability of SCLC cells to leave the primary tumor and establish inoperable metastases is a major cause of death and a serious impediment to successful therapy (van Meerbeeck et al., 2011) . Molecular analysis of metastatic progression of human cancer is limited by the difficulty in accessing tumor samples at defined stages. This problem is especially true for SCLC, since patients with metastatic disease rarely undergo surgery. Genetically engineered mouse models of human SCLC recapitulate the genetics, histology, therapeutic response, and highly metastatic nature of the human disease (Meuwissen et al., 2003; Schaffer et al., 2010) . These models recapitulate cancer progression in a controlled manner and allow isolation of primary tumors and metastases directly from their native microenvironment.
Here, we analyzed SCLC cells from primary tumors and metastases to identify global changes in chromatin accessibility during metastatic progression. We uncovered an unexpectedly dramatic increase in accessibility that occurs during malignant progression. We determined that high expression of a single transcription factor, Nfib, alters chromatin state globally and enacts a program of gene expression that promotes multiple steps of the metastatic cascade.
RESULTS

Identification of Two Distinct Chromatin Accessibility Landscapes within SCLC
To specifically mark cancer cells, we bred a Cre-reporter allele (R26 mTmG ) into the Trp53 f/f ;Rb1 f/f ;p130 f/f mouse model of human SCLC (Muzumdar et al., 2007; Schaffer et al., 2010 (Schaffer et al., 2010) . These mice develop multifocal metastases in the liver, one of the most common sites of SCLC metastasis in humans ( Figure 1B ) (Nakazawa et al., 2012; Meuwissen et al., 2003) . We isolated cells from individual primary tumors and metastases by fluorescence-activated cell sorting (FACS; Figures 1C , S1A, and S1B). We used the assay of transposase-accessible chromatin using sequencing (ATAC-seq) to determine the genome-wide chromatin accessibility landscape in primary tumors and liver metastases from TKO-mTmG mice (Buenrostro et al., 2013) . Figure S1 .
We isolated cancer cells from one large primary tumor and one liver macro-metastasis from each of four mice. All ATAC-seq samples were enriched for reads at transcription start sites (TSSs) and exhibited the expected periodicity of insert length (Figures S1C-S1E). Hierarchical clustering based on the correlation of accessibility separated the samples into two groups: one containing the majority of primary tumors and the other containing the majority of metastases ( Figure 1D ). The first principal component of variation also separated the samples into the same two groups and explained 58% of the variance (Figures S1F and S1G) .
We assessed differential accessibility between these two groups and discovered that $24% of all accessible regions were >2-fold more accessible in the predominantly metastatic group ( Figures 1E, 1F , S1H, S2A, and S2B). Conversely, only $0.5% of peaks were >2-fold more accessible in the primary-tumor-enriched group, and thus we defined these chromatin states as ''hyper-accessible'' and ''hypo-accessible.'' To put the magnitude of these chromatin differences in context, we reanalyzed our ATAC-seq data and published DNase-seq data from distinct tissues and cell types (Vierstra et al., 2014) . Interestingly, the fraction of peaks that differ between the hypo-and hyper-accessible SCLC cell states is smaller than that detected between lung and liver, but greater than between lymphocyte subsets. The nearly unidirectional increase in accessibility during SCLC progression is also a distinct feature of this cell state change ( Figure 1G ).
Differentially Accessible Regions Are in Gene Deserts, Evolutionarily Conserved, and Shared by Other Cell Types The differentially accessible regions were largely gene distal, with relatively few promoter-proximal regions exhibiting differential accessibility (Figures 2A and S2C ). Large genomic domains (on the order of 1 to 10 Mb) were more likely than others to have differentially open regions (over 90% of the newly open peaks were in these domains, which contain less than 40% of constitutively open peaks, p < 1 3 10 À12 by Fisher's exact test) ( Figure 2B ). Domains enriched for differentially accessible peaks were characterized by significantly lower gene density and late replication timing ( Figures 2C, 2D , and S2D). Genepoor domains have been classically thought to be less important in regulating gene expression. However, the differentially open intergenic regions were enriched for evolutionarily conserved sequences, suggesting that a subset of these regions may be regulatory elements that promote SCLC progression ( Figure 2E ). To determine whether these differentially accessible regions are common to other cell types or represent a pattern of accessibility unique to metastatic SCLC, we compared our chromatin accessibility data to DNase-seq from other cell types and tissues (Vierstra et al., 2014) . The constitutively open regions were not dramatically enriched in any particular cell type ( Figure S2E ). However, the differentially open regions had the greatest overlap (>50%) with open regions in brain tissues (Figure 2F) , suggesting that neuroendocrine SCLC tumor cells may co-opt regulatory elements found in neuronal tissue during cancer progression.
Differentially Accessible Regions Are Highly Enriched for NFI Binding Motifs
To identify potential drivers of this dramatic difference in accessibility, we determined the enrichment of transcription factor motifs within the differentially accessible regions, compared to those within constitutively open regions. The most highly enriched motif was the binding site for the NFI family of DNA binding factors ( Figure 3A) , which can bind either a full site of two inverted 5-bp repeats or a half site with lower affinity (Meisterernst et al., 1988) . De novo motif enrichment also assembled the NFI half-site motif, and one or more de novo-assembled half sites were present in over 90% of the differentially open regions (Figures 3B and S3A) . These data suggest that NFI transcription factors might play an important role in the large-scale chromatin accessibility changes observed during SCLC progression.
The Hyper-Accessible Samples Are Characterized by Nfib Copy Number Amplification NFI transcription factors (Nfia, Nfib, Nfic, and Nfix) are widely expressed and the DNA-binding domain is distinct from other DNAbinding factors (Gronostajski 2000) . We quantified DNA copy number based on ATAC-seq reads outside of accessible regions and found that the hyper-accessible samples specifically had genomic amplification of the Nfib locus ( Figure 3C ) (Dooley et al., 2011) . DNA copy number gains at Mycl1 or any other loci did not correlate with the hypo-or hyper-accessible states (Table S1 ). Figure 3F ).
Nfib Is Highly Expressed in
Disseminated tumor cells in the pleural fluid were also almost universally Nfib pos , suggesting that the Nfib pos cell state has the unique ability to overcome the initial hurdles that limit systemic spread.
NFIB Is Highly Expressed in a Subset of Human SCLC Primary Tumors and Metastases NFIB is genomically amplified in 5%-15% of human primary SCLC tumors, consistent with high NFIB RNA expression in a subset of primary SCLC samples and cell lines ( Figures S3C  and S3D ) (Dooley et al., 2011; George et al., 2015; Peifer et al., 2012; Rudin et al., 2012; Barretina et al., 2012) . By IHC, NFIB was moderately to highly expressed in $50% of primary human SCLCs, as well as in lymph node and distant metastases, with a trend toward higher expression in distant metastases (Figures S3E and S3F) . Patients with stage IV SCLC had tumors with significantly higher NFIB levels than did stage See also Figure S3 and Table S1 .
I and stage II patients, and patients with higher NFIB had a trend toward shorter overall and progression-free survival .
Genomic Regions Containing NFI Motifs Have Increased Occupancy in Hyper-Accessible Samples
To approach the question of how increased expression of Nfib could lead to widespread opening of genomic loci, we employed transcription factor footprinting, which uses ATAC-seq reads to infer binding based on the steric hindrance between transcription factor complexes and the Tn5 transposase used to fragment the genome (Buenrostro et al., 2013) . We detected an extremely clear footprint of transcription factor occupancy around the aggregated NFI full sites in accessible regions, suggesting that the NFI-DNA interaction is long-lived (Sung et al., 2014) (Figure 3G) . None of the other transcription factors motifs enriched in the hyper-accessible state showed clear differential footprinting in the hypo-versus hyper-accessible chromatin state (data not shown).
We observed a clear pattern of ATAC-seq fragment sizes around NFI motif sites, allowing us to use this information in addition to insertion frequency to infer NFI occupancy at individual sites ( Figures S3J and S3K ). We divided NFI sites based on their similarity to the consensus NFI position weight matrix (a proxy for biochemical affinity) (Benos et al., 2002 ) and compared the inferred occupancies of sites within each bin for the hypo-and hyper-accessible chromatin states. The hyper-accessible chromatin state was characterized by increased occupancy of sites, particularly at sites of intermediate affinity, supporting a model in which increased expression of Nfib drives binding to less canonical sites ( Figure 3H ). NFI sites in differentially accessible regions had even higher occupancy than constitutively open sites, suggesting that they are especially amenable to Nfib binding, beyond what would be expected from their motif quality alone ( Figure 3H ).
Occupancy by NFI Depletes Nucleosomes and Changes Local Chromatin Architecture
Nucleosomes and transcription factors compete for access to DNA such that increased occupancy of NFI sites may deplete nucleosomes, thereby inducing accessibility changes at NFI sites genome-wide (Bell et al., 2011) . By inferring nucleosome occupancy using the insert sizes of the ATAC-seq reads (Schep et al., 2015) , we found that differentially open regions were more depleted of nucleosomes around NFI sites in hyper-accessible samples ( Figure 3I ). The amount of nucleosome depletion was dependent on the occupancy of NFI motifs, such that higher affinity NFI sites were associated with greater depletion of nucleosomes, but lower affinity sites were associated with greatest differential nucleosome depletion between the two chromatin states (Figures S3L and S3M) .
These data support a model in which Nfib stably binds DNA and directly competes with nucleosomes to stabilize an accessible chromatin configuration. These results suggest that Nfib upregulation may initiate and maintain chromatin state transitions, ultimately leading to transcriptional changes associated with a gain in metastatic ability.
SCLC Cell Lines Recapitulate the Differential Chromatin States Associated with Nfib Expression
To determine whether SCLC cell lines maintain the chromatin landscapes of the in vivo tumors, we assessed Nfib expression and the chromatin state of six murine SCLC cell lines (Figures 4A-4C ). The two cell lines with highest Nfib protein expression (KP1 and 16T) had Nfib genomic amplification (Figures 4A and 4B Figures 5B and S5C ). Regions that close upon Nfib knockdown were generally anticorrelated with accessibility changes between hypo-and hyper-accessible ex vivo samples (r = À0.55). Indeed, the majority of regions (82%) that were differentially open in the hyper accessible class relied on Nfib to maintain accessibility ( Figure 5C ). The regions that decrease in accessibility in Nfib knockdown cells were generally gene-distal and highly enriched for NFI sites ( Figures S5D and S5E) . The large majority (75%) of these regions showed differential Nfib occupancy based on Nfib ChIP-seq, and, on average, they had increased nucleosome occupancy at NFI motif sites ( Figure 5D ). These results demonstrate that Nfib maintains chromatin accessibility and local chromatin architecture. See also Figure S4 . Figure 5G ). Conversely, >60% of the metastases in mice with 16TshNfib tumors expressed Nfib ( Figure 5G ). This dramatic selection for Nfib expression in metastases further underscores the strong metastatic fitness advantage conferred by Nfib.
Subcutaneous growth of a second Nfib high SCLC cell line (KP1) was likewise unaffected by Nfib knockdown, and KP1shNfib tumors also seeded $2.5-fold fewer liver metastases than KP1shControl tumors ( Figures S5G and S5H) . The Nfib pos cells that escaped Nfib knockdown outcompeted Nfib neg cells to an even greater extent within KP1shNfib subcutaneous tumors than within 16TshNfib subcutaneous tumors, and the metastases that formed were almost exclusively Nfib pos ( Figure S5I ).
We further investigated the role of Nfib in conferring metastatic ability using intravenous transplantation of 16TshControl and 16TshNfib cells. 16TshNfib cells seeded fewer metastases than control cells, and more than half of the metastases that formed from 16TshNfib cells escaped Nfib knockdown ( Figures  5H-5J ), indicating that Nfib is also required for later stages of the metastatic process.
Nfib Is Required for Clonal Growth and the Invasive Ability of SCLC Cells
Nfib knockdown reduced proliferation but had no consistent impact on cell death under standard culture conditions ( Figures  S5J-S5Q ). Because these SCLC cell lines grow in culture as floating spheres, reduced proliferation suggested that Nfib may influence anchorage-independent growth. To directly assess clonal growth in anchorage-independent conditions, we plated shControl and shNfib cells in soft agar. Nfib knockdown greatly reduced the ability of SCLC cells to expand into colonies under these conditions ( Figures 5K, S5R , and S5S). Nfib knockdown also greatly reduced migration ( Figures 5L, S5T , and S5U). These results indicate that Nfib controls several cellular phenotypes that likely cooperate to drive metastatic ability.
Nfib Is Sufficient to Open a Subset of Distal Regulatory Regions
To determine whether Nfib is also sufficient to drive these changes in chromatin state and metastatic ability, we generated an Nfib low cell line with doxycycline-inducible Nfib expression (KP22-TRENfib; Figure 6A ). ATAC-seq on KP22-TRE-Nfib and KP22-TRE-empty cells after doxycycline treatment indicated that Nfib expression was sufficient to rapidly drive chromatin opening of $1,800 regions ( Figures 6B and S6A ). These regions were highly enriched for loci that were more open in the hyper-accessible ex vivo samples, as well as for regions that had reduced accessibility in Nfib-knockdown cells (Figures 6C and S6A) . The regions that opened with Nfib expression were largely gene-distal, were enriched for NFI motifs, and had high overlap with the differential Nfib ChIP signal in the Nfib high versus the Nfib low lines (60% overlap, p < 1 3 10 À300 by hypergeometric test; Figures S6B and S6C ).
Unlike Nfib knockdown, which reduced accessibility at many regions, Nfib overexpression increased accessibility at only a subset of sites that had slightly higher motif scores and slightly higher overlap with putative regulatory elements in other cell types ( Figures 6C, S6D, and S6E ). The affinity of NFI factors to DNA has been shown to be reduced by up to 300-fold by the presence of nucleosomes (Blomquist et al., 1996) , suggesting NFI is not a classically defined ''pioneer'' transcription factor capable of evicting nucleosomes directly from nucleosome-bound DNA (Zaret and Mango 2016) . The sites sensitive to Nfib induction had modest but above-background accessibility in the Nfib low cell line prior to induction of Nfib expression ( Figures 6D and  6E ). Those sites that were newly open in the hyper-accessible samples, but not sensitive to Nfib overexpression, were not significantly open relative to the background in this cell line (Figure 6E) , suggesting that Nfib sensitivity may require a permissive level of accessibility to allow Nfib-mediated changes in the nearby chromatin landscape. Further supporting this hypothesis, the hypo-accessible samples had modest accessibility above background in the sites that were differentially open ( Figure S6F ).
To extrapolate our findings to human SCLC, we tested whether NFIB is sufficient to increase chromatin accessibility in human SCLC cells. Expression of NFIB in two NFIB low human SCLC cell lines increased chromatin accessibility at a subset of regions in both cell lines (Figures S6L and S6M) . Consistent with the effect of Nfib in the mouse SCLC cell lines, NFIB expression predominantly led to increased accessibility at distal regulatory regions that were enriched for NFI motifs ( Figure S6M ). Human cell lines with NFIB overexpression showed increased occupancy of NFI sites, to an even greater degree than in mouse cell lines ( Figure S6N ).
Nfib Is Sufficient to Drive Clonal Growth In Vitro and Metastatic Ability In Vivo
To determine whether Nfib expression is also sufficient to increase clonal growth in cell culture, we quantified the ability of KP22 cells with either inducible or constitutive Nfib expression to form colonies in anchorage-independent conditions. In both cases, Nfib expression greatly increased the clonal growth ability of SCLC cells ( Figures 6F and S6J ). Nfib expression did not consistently alter cell death in vitro, but increased proliferation under standard suspension growth conditions (data not shown). NFIB expression in human SCLC cells also increased cell growth under standard suspension growth conditions, as well as in anchorage-independent conditions ( Figures S6O-S6R) . Consistent with our functional data from Nfib knockdown cells, KP22-Nfib cells formed $3-fold more liver metastases after intravenous transplantation relative to controls (Figures 6G-6I) . Notably, the few metastases that formed from KP22 control cells 
(legend continued on next page)
had high Nfib expression (data not shown), suggesting a strong selection for Nfib high cells during the post-intravasation steps of the metastatic cascade. Nfib expression did not change subcutaneous tumor growth, confirming that Nfib has a limited effect on SCLC growth in vivo ( Figure S6K ; data not shown).
Nfib Promotes Neuronal Gene Expression Programs
Our results establish that Nfib modulates accessibility of many distal, putative regulatory regions of the genome. To identify what gene expression programs enable the metastatic phenotype of Nfib high tumors, we examined gene expression changes upon Nfib overexpression and knockdown ( Figure S7A ). Approximately 500 genes were significantly upregulated with Nfib overexpression and a similar number of genes changed after Nfib knockdown (Figures S7B-S7D) .
Almost all (92%) of the genes that significantly changed with both overexpression and knockdown changed reciprocally (Figure 7A) . The genes that were upregulated with Nfib overexpression and downregulated with Nfib knockdown were enriched for gene ontology annotations associated with neuronal function, including axon guidance, synapse organization, and regulation of nervous system development ( Figures 7B and S7E ).
Gene Expression Changes Are Associated with Distal
Regions that Become Accessible upon Nfib Upregulation Interestingly, we observed Nfib-driven neuronal-associated gene expression programs and a high fraction of Nfib-driven chromatin accessibility changes overlap with putative regulatory elements found in brain tissue (>70%; Figures 7C and S6E) . Thus, two distinct datasets (gene expression and chromatin accessibility) link neuronal programs to the metastatic ability of this neuroendocrine cancer.
Nfib appears to drive chromatin accessibility at largely genedistal regions of the genome. Examining 100 kb windows around genes that were upregulated with Nfib overexpression and downregulated with Nfib knockdown uncovered a strong enrichment for gene-distal regions that increased in accessibility with Nfib overexpression ( Figure 7D ). Having only an Nfib ChIP peak at the promoter (in any cell line) did not have a significant effect on gene expression with Nfib overexpression (Figure 7E ), indicating that direct action at the promoters is not the primary mode of gene regulation by Nfib. Collectively, our data support a model in which Nfib stabilizes the open chromatin state at distal regulatory elements in SCLC cells, thereby inducing a gene expression program related to neuronal-associated processes that drive metastatic ability ( Figures 7F and 7G ).
DISCUSSION Nfib Drives Multiple Steps of the Metastatic Process
Metastasis is a low-probability, multistep process in which cancer cells from primary tumors must invade the local tissue, disseminate, survive in circulation, extravasate into a secondary site, and expand into a tissue-destructive metastasis. The early spread and high frequency of metastasis in SCLC patients could suggest that SCLC cells inherently possess the capacity to metastasize (Hou et al., 2012) . In contrast, our work shows that SCLC tumors can gain metastatic ability through a dramatic remodeling of their chromatin state ( Figure 7G ). Our results highlight the power of combining genome-wide molecular approaches with genetic model systems to uncover hidden variations in cellular states.
Our data demonstrate that a single transcription factor, Nfib, promotes the ability of SCLC cells to perform several of the requisite steps to metastasize, including invasion, dissemination, and clonal growth. We confirmed moderate to high NFIB expression in human SCLC and showed that NFIB overexpression increases anchorage-independent growth and induces chromatin changes in human SCLC cell lines (Dooley et al., 2011) . These data suggest that a subset of human SCLCs likely use NFIB-driven changes in chromatin state as their route for metastasis, although alternative pathways likely exist. A more complete understanding of all pathways by which human SCLC gains metastatic ability, NFIB-driven or otherwise, would allow for better patient stratification and the improved division of SCLC into subtypes based on their pro-metastatic programs.
The Stable and Highly Metastatic SCLC State Drives Rampant Metastatic Spread Across many cancer types, loss of differentiation correlates with aggressiveness and poor patient outcome; however, in SCLC, the link between dedifferentiation and aggressiveness has remained unclear. Amplification of pluripotency factors drives aggressive SCLC (Rudin et al., 2012; Lin et al., 2012) , and inhibition of a histone lysine demethylase, which is known to maintain pluripotency in human embryonic stem cells, delays SCLC growth (Mohammad et al., 2015) . Conversely, lineage differentiation pathways driven by Ascl1 and NeuroD1 also promote SCLC tumorigenesis and progression (Augustyn et al., 2014; Osborne et al., 2013) . Our data suggest an alternate model, in which partial transdifferentiation driven by Nfib creates a neuronal program of gene expression that drives metastatic ability (Figures 7B, 7G, and S7E) .
Unlike the epithelial-mesenchymal transition, which is proposed to create a transient, highly metastatic state (Yang and Weinberg 2008) , Nfib amplification, overexpression, and the resulting chromatin changes create a stable and highly metastatic state maintained in metastases. This finding may shed light on why SCLC is so widely metastatic in patients: established Nfib-driven metastases remain in a highly metastatic state and may continuously seed additional secondary metastases (Hou et al., 2012) .
Mechanism of Targeting Nfib to Functional Sites
Nfib's inability to bind nucleosome-bound DNA suggests that it does not act as a canonical pioneer factor (Zaret and Mango 2016; Blomquist et al., 1996) . Our data suggest that Nfib-sensitive sites exist in a ''preset'' configuration that permits binding of these motifs when Nfib is upregulated. On average, these preset sites are characterized by modest, but above-background accessibility and an absence of Nfib binding ( Figures 6D and 6E) . It is notable that such large numbers of preset sites exist in SCLC cells. The ease with which Nfib can reconfigure the chromatin state of SCLC cells indicates that the initial cancerous state may be prone to conversion toward a metastatic state.
Several mechanisms could establish this preset architecture. Foxa transcription factors are pioneer factors that interact with (E) Average change in expression with Nfib overexpression of four gene categories. Promoter binding, genes with promoter-proximal ChIP peaks within 1 kb of TSS. Nfib-sens. distal region, genes with a distal, Nfib-sensitive region within 100 kb of the TSS that opens with Nfib overexpression. Error bars are 95% confidence intervals. ns, not significant; **p < 1x10 À7 by Mann-Whitney U test.
(F) Example locus showing Nfib ChIP-seq (top two panels) and ATAC-seq data. Black squares below each set of tracks represent significantly changed regions. (G) Model for Nfib-dependent metastatic progression. See also Figure S7 and Table S2 .
NFI in other cell types, and Foxa motifs are enriched around the NFI sites more bound in the Nfib high cell lines ( Figure S4J ) (Grabowska et al., 2014) . A fraction of sites, therefore, may rely on Foxa factors to maintain a permissive chromatin state around NFI sites, marking them for opening on Nfib upregulation. Histone turnover in active regulatory regions may also enable sensitivity to Nfib expression, possibly through the action of chromatin remodelers (Hebbar and Archer 2003; Deal et al., 2010) .
Molecular Mechanism of Chromatin Opening and Gene Activation
How does Nfib establish an open chromatin architecture after binding? Nfib gives an especially strong ''footprinting'' signal in our ATAC-seq data, a feature associated with a slow DNA binding off-rate (Sung et al., 2014) . Furthermore, the high affinity of NFI to its consensus full site (Meisterernst et al., 1988 ) implies a long half-life similar in magnitude to the longest-lived transcription factors (Sung et al., 2016) . This distinguishes Nfib from other transcription factors that are thought to have short residence time on DNA and are insufficient to compete with nucleosomes or other transcription factors (Sung et al., 2016; Voss and Hager 2014) . The long residence time of Nfib on DNA likely allows the adaptation of nearby chromatin and enforces a prototypical chromatin architecture with positioned nucleosomes. This architecture is supported by the depleted nucleosome occupancy and positioned proximal nucleosomes around NFI sites in the hyper-accessible state ( Figure 3I ). Many additional motifs are enriched around newly open sites, and binding at these motifs may help stabilize an open structure ( Figures 3A, S4J , and S6B). Our data do not rule out Nfib-induced destabilization of higher-order nucleosome interactions (Alevizopoulos et al., 1995) or recruitment of chromatin remodelers (Hebbar and Archer 2003) , but rather suggests that these mechanisms could complement the direct nucleosome depletion and positioning effects of Nfib. Our data indicate that Nfib establishes a pro-metastatic gene expression program through stabilizing chromatin accessibility at distal regulatory elements. Increased Nfib occupancy in the absence of increased accessibility is only weakly associated with increased gene expression, while Nfib-driven increases in distal accessibility are associated with upregulation of nearby genes ( Figures 7D, S7E , and S7F). Nfib has diverse functions and has been shown to both promote cell differentiation during development and maintain populations of stem cells in adult tissues (Harris et al., 2015; Gronostajski 2000; Chang et al., 2013 ). An implication of our study is that maintenance of open chromatin architecture by Nfib may promote varied functional outcomes through combinatorial binding of nearby transcription factors.
Nfib Regulates Neuronal Guidance and Migration Pathways Our data suggest that incorporating features of a neuronal-like program into the SCLC state promotes metastatic ability. Nfib is important for brain development and neuronal migration, and several of the neuronal-associated Nfib-regulated genes and pathways (including Cxcr4, the Eph receptors, Semaphorins, Netrin-1, and Slit/Robo families) have been implicated in invasion and metastasis of other cancer types (Steele-Perkins et al., 2005; Betancourt et al., 2014; Burger et al., 2003; Vanharanta et al., 2013; Chen 2012; Foley et al., 2015; Ko et al., 2014; Zhou et al., 2011) . Our results suggest that overlapping components of a neuronal program with the transformed SCLC state can drive the insidious metastatic ability of this cancer type.
Epigenetic machinery has recently emerged as a promising therapeutic target, and preclinical results from modulating components of these pathways have been encouraging (Mohammad et al., 2015) . Progression to pro-metastatic epigenetic states may create collateral therapeutic vulnerabilities or provide direct targets to limit the development of initial metastases or halt the propagation of secondary metastases. Given the dramatic remodeling of the gene regulatory state driven by a single factor in SCLC, we speculate that other major cancer types may also gain metastatic proclivity through large-scale remodeling of their chromatin state.
EXPERIMENTAL PROCEDURES
Mouse Model
All experiments were performed in accordance with Stanford University's Animal Care and Use Committee guidelines. Trp53 flox , Rb1 flox , p130 flox , and R26 mTmG mice have been described previously (Schaffer et al., 2010; Muzumdar et al., 2007) . Tumors were initiated by inhalation of Adeno-CMV-Cre (University of Iowa Vector Core).
ATAC-Seq Library Preparation and Differential Accessibility 5 3 10 4 cells were from ex vivo tumors or from cell culture directly. ATAC-seq libraries were generated as described previously (Buenrostro et al., 2013) . Peaks were called on the merged set of all ex vivo ATAC-seq reads using MACS2 (Zhang et al., 2008) and filtered to remove putative copy number altered regions. The number of reads/peak was determined for each sample using bedtools multicov, and the relative sequencing depth was estimated using a set of ''housekeeping'' peaks at transcription start sites of genes that were uniformly expressed across TKO-mTmG tumors. Differential accessibility was assessed using DESeq2 (Love et al., 2014) . Unless otherwise stated, regions were called differentially accessible if the absolute value of the log2 fold change was 0.5 at an FDR <0.1. Visualizations of insertion tracks were smoothed by 150-bp sliding windows (20-bp step size).
Transcription Factor Occupancy
For each motif site, the distribution of fragments as a function of fragment size and midpoint position relative to the motif center was fit to a mixture model that finds the optimal mixture parameter between two generating distributions: (1) the distribution from an ideal ''bound'' model modulated by local sequence bias and (2) the distribution from an ''unbound'' model in which fragments are distributed based only on the local sequence bias. Local sequence bias was modeled (Schep et al., 2015) , and the ideal ''bound'' model was found by aggregating reads around motif sites with high motif scores (>7.6) and divided by the expectation given sequence bias at those sites.
Nfib Knockdown and Overexpression
Stable Nfib knockdown cell lines were generated using lentiviral pLKO/PuroR vectors. Knockdown was confirmed by qRT-PCR and western blotting. Inducible and constitutive Nfib-expressing human and mouse cells were generated using lentiviral vectors.
Transplantation and Cell Culture Assays
For intravenous transplantation, 2 3 10 4 cells were injected into the lateral tail vein of NOD/SCID/gc (NSG) mice. For subcutaneous injection, 5 3 10 4 cells were resuspended in 100 ml PBS and mixed with 100 ml Matrigel (Corning, 356231) with four injection sites per mouse. Cell culture assays were performed using standard protocols.
RNA-Sequencing Expression Analysis
RNA-sequencing (RNA-seq) libraries were prepared using the Illumina TruSeq Kit (v.2), according to the manufacturer's instructions. RNA-seq reads were separately aligned to the mouse genome (mm10) using TopHat. Read counts within merged exons (RefSeq) were found and compared using DESeq2. Size factors were estimated from cqnnorm using the exon length and average GC content as covariates in the normalization.
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